merged_colon-cancer-blood-test-shield.txt
<question_number>1</question_number>
<answer>Poor at detecting precancerous polyps</answer>
<question_number>2</question_number>
<answer>Colonoscopy</answer>
<question_number>3</question_number>
<answer>Simpler convenience through a routine blood test</answer>
<question_number>4</question_number>
<answer>Its inability to detect precancerous polyps for cancer prevention</answer>
<question_number>5</question_number>
<answer>It was approved because its ease of use may increase screening rates despite not preventing cancer by detecting polyps</answer>
<question_number>6</question_number>
<answer>Its convenience as a blood test, similar to challenges with other screenings, coupled with a new limitation in detecting polyps</answer>
<question_number>7</question_number>
<answer>Its very low detection rate for large, precancerous polyps</answer>
<question_number>8</question_number>
<answer>Its ease of administration aligns with current screening challenges, but its inability to detect precancerous growths creates a new barrier in prevention</answer>
<question_number>9</question_number>
<answer>It is significantly worse at finding precancerous polyps</answer>
<question_number>10</question_number>
<answer>Because it may encourage more people to get screened despite its inability to detect precancerous growths</answer>